首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >P-Selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction
【24h】

P-Selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction

机译:暴露于P选择素和CD63的血小板微粒反映了外周动脉疾病和心肌梗死中的血小板活化

获取原文
           

摘要

Background: Platelet-derived microparticles (PMPs) are generally considered a marker of platelet activation in cardiovascular disease. We studied the extent to which PMP subpopulations parallel platelet activation in vitro and in vivo.Methods: Using flow cytometry, we analyzed PMP subpopulations from resting and activated platelets in vitro (n = 6) as well as from plasma samples of patients with stable angina, peripheral arterial disease, or myocardial infarction [non-ST-elevation (NSTEMI) and ST-elevation (STEMI)] and from older, age- and sex-matched and young healthy individuals [n = 10 for all groups except NSTEMI (n = 11)]. Coagulation markers prothrombin fragment F1 + 2 and thrombin-antithrombin complexes were determined by ELISA. The PMP-associated fraction of soluble (s)P-selectin was estimated by ELISA.Results: In vitro, stimulation of platelets with thrombin receptor–activating peptide (15 μmol/L) or the calcium ionophore A23187 (2.5 μmol/L) increased fractions of both platelets and PMPs exposing P-selectin or CD63 ( P 0.001 for all). Whereas the number of PMPs released by A23187-stimulated platelets increased significantly ( P 0.001), the number of PMPs released from thrombin receptor-activating peptide–stimulated platelets remained constant ( P 0.05). Ex vivo, numbers of circulating PMPs were comparable in all groups. Compared with young persons, P-selectin–exposing PMPs were increased in older persons ( P = 0.02) and were further increased in patients with NSTEMI ( P = 0.007) and STEMI ( P = 0.045). CD63-exposing PMPs were increased in patients with peripheral arterial disease ( P = 0.041), NSTEMI ( P = 0.001), and STEMI ( P = 0.049). Subpopulations exposing P-selectin or CD63 correlated with each other ( r = 0.581; P 0.001), but neither correlated with the plasma concentrations of F1 + 2 or thrombin–antithrombin complexes. The PMP-associated fraction of sP-selectin constituted only 2.2 (4.7)% [mean (SD)] of total sP-selectin.Conclusions: PMP subpopulations reflect platelet activation status better than the total number of PMPs. Increased concentrations of circulating PMP subpopulations are found in aging, and further increases are encountered in peripheral arterial disease and myocardial infarction.
机译:背景:血小板源微粒(PMP)通常被认为是心血管疾病中血小板活化的标志。方法:使用流式细胞仪分析体外静息和活化血小板(n = 6)以及稳定型心绞痛患者血浆中的PMP亚群,周围动脉疾病或心肌梗死[非ST抬高(NSTEMI)和ST抬高(STEMI)]以及来自年龄,年龄和性别匹配以及年轻健康个体的数据[n = 10,除NSTEMI外,所有组(n = 11)]。通过ELISA测定凝血标记物凝血酶原片段F1 + 2和凝血酶-抗凝血酶复合物。通过ELISA评估可溶性(s)P-选择蛋白的PMP相关分数。结果:在体外,凝血酶受体激活肽(15μmol/ L)或钙离子载体A23187(2.5μmol/ L)对血小板的刺激作用增加血小板和PMP的小部分暴露于P-选择素或CD63(所有P均<0.001)。 A23187刺激的血小板释放的PMP数量显着增加(P <0.001),而凝血酶受体激活肽刺激的血小板释放的PMP数量则保持恒定(P> 0.05)。离体后,所有组中循环中PMP的数量均相当。与年轻人相比,老年人中暴露于P-选择素的PMPs升高(P = 0.02),而NSTEMI(P = 0.007)和STEMI患者(P = 0.045)则进一步升高。患有外周动脉疾病(P = 0.041),NSTEMI(P = 0.001)和STEMI(P = 0.049)的患者,暴露于CD63的PMP升高。暴露P-选择蛋白或CD63的亚群彼此相关(r = 0.581; P <0.001),但与F1 + 2或凝血酶-抗凝血酶复合物的血浆浓度均不相关。 sP-选择素的PMP相关部分仅占总sP-选择素的2.2(4.7)%[平均值(SD)]。结论:PMP亚群反映的血小板活化状态好于PMP的总数。在衰老中发现循环PMP亚群的浓度增加,并且在外周动脉疾病和心肌梗塞中进一步增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号